How To Fix Remark Code M193 (RARC) | Common Reasons, Next Steps & How To Avoid It

Remark Code MA84 means that the patient has been identified as participating in the National Emphysema Treatment Trial, but there is a discrepancy in the records. This code is used to indicate that the patient is either not a participant in the trial or has not yet been approved for this phase of the study. It is important to contact Johns Hopkins University, the study coordinator, to resolve this discrepancy.

1. Description

Remark Code MA84 indicates that the patient has been identified as participating in the National Emphysema Treatment Trial, but there is a discrepancy in the records. The official description states: ‘Patient identified as participating in the National Emphysema Treatment Trial but our records indicate that this patient is either not a participant, or has not yet been approved for this phase of the study.’ This code is used to alert healthcare providers and insurance companies about the need to resolve any discrepancies related to the patient’s participation in the trial.

2. Common Reasons

1. Discrepancy in patient’s participation: This may occur if the patient’s information was not accurately recorded or updated in the trial’s database.
2. Lack of approval for the specific phase of the study: The patient may be participating in the trial but has not yet been approved for the particular phase mentioned in the claim.

3. Next Steps

1. Contact Johns Hopkins University: It is crucial to reach out to Johns Hopkins University, the study coordinator, to resolve any discrepancies or issues related to the patient’s participation in the National Emphysema Treatment Trial.
2. Provide necessary documentation: Gather all relevant documentation, such as the patient’s trial enrollment details and any correspondence with the study coordinator, to support the resolution process.

4. How To Avoid It

1. Ensure accurate recording of patient’s trial participation: Healthcare providers should double-check and update the patient’s trial participation information in the trial’s database to avoid any discrepancies.
2. Verify approval for the specific phase of the study: Before submitting a claim, confirm that the patient has been approved for the particular phase mentioned in the claim.
3. Maintain clear communication with the study coordinator: Regularly communicate with the study coordinator to stay updated on the patient’s trial participation status and address any potential issues promptly.

5. Example Cases

1. Case 1: A claim is denied because the patient’s records indicate that they are not a participant in the National Emphysema Treatment Trial, highlighting the need to resolve the discrepancy.
2. Case 2: A claim adjustment occurs because the patient has not yet been approved for the specific phase of the study mentioned in the claim, emphasizing the importance of verifying approval before submitting the claim.

Source: Remittance Advice Remark Codes